...
首页> 外文期刊>Der Pharmacia Lettre >Formulation and In Vitro Evaluation of Pulsatile Colon DrugDelivery System of Piroxicam using 32 Factorial design
【24h】

Formulation and In Vitro Evaluation of Pulsatile Colon DrugDelivery System of Piroxicam using 32 Factorial design

机译:使用32因子设计的吡罗昔康脉动结肠给药系统的配制和体外评估

获取原文
           

摘要

The aim of the present investigation was to develop colon specific double cross linked alginatechitosan blend gel beads for pulsatile release. A 32 factorial design was employed to study the influence of two independent variables amount of piroxicam (X1), amount of chitosan (X2) on dependent variables, encapsulation efficacy (YEE), amount of drug release at 5th hour (Y5) and amount of drug release at 6th hour (Y6). The prepared colon specific pulsatile beads were evaluated for particle size and invitro drug release studies. Drug polymer interaction studies were determined by fourier transform infrared (FTIR) spectroscopy. The surface characteristics and morphology was determined by scanning electron microscopy (SEM). The check point batch was prepared and the contour and 3D plots were also presented. It was concluded that the desired colon specific pulsatile release was obtained with alginate-chitosan blend gel double cross linked beads.
机译:本研究的目的是开发用于脉动释放的结肠特异性双交联藻酸壳聚糖共混凝胶珠。采用32因子设计来研究两个独立变量的比洛昔康(X1),壳聚糖(X2)的数量对因变量,包囊功效(YEE),第5小时药物释放的数量(Y5)的影响。第6小时(Y6)释放药物。评价制备的结肠特异性搏动性珠的粒度和体外药物释放研究。药物聚合物相互作用的研究是通过傅立叶变换红外(FTIR)光谱法确定的。通过扫描电子显微镜(SEM)确定表面特征和形态。准备了检查点批次,并且还显示了轮廓图和3D图。结论是用藻酸盐-壳聚糖共混凝胶双交联珠获得了所需的结肠特异性脉动释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号